BioAdvance - Press Releases
Newsroom >> News Releases

News Releases

2010   |   2009   |   2008   |   2007   |   2006   |   2005   |   2004   |   2003   |   2002   |   2001

2006

November 28, 2006

BioAdvance Announces New Board Chairman    
Dr. Russel E. Kaufman, President and CEO of The Wistar Institute, Appointed       
> View Press Release
November 13, 2006

Yaupon Therapeutics Closes $4 Million Financing  ---  Series B financing positions company to advance development of its product portfolio targeting cancer and central nervous system diseases
> View Press Release
November 6, 2006

Melior Announces Research Collaboration with Merck
> View Press Release
October 16, 2006

BioAdvance Launches Rolling Process for Life Sciences Businesses Seeking Early-Stage Investment -- Investment Team Expanded
> View Press Release
September 13, 2006

NuPathe Closes $15 Million in Financing
> View Press Release
August 16, 2006

NuPathe Licenses Novel Drug Delivery Technology from University of Pennsylvania to Support Development of Therapies to Treat Neurologic and Psychiatric Disorders
> View Press Release
July 26, 2006

InfraScan Announces First Patients Enroll in Clinical Trials in Brain Hematoma Detection
Handheld imaging device for early detection of brain bleeding in head trauma patients begins trials at two prestigious academic medical centers
> View Press Release
May 17, 2006

BioAdvance Invests in Midway Pharmaceuticals to Support Promising Development Program for GI Therapies
> View Press Release
May 1, 2006

Gelleon Pharmaceuticals is Named 'SR One Biotech Company of the Year' for  Innovative Approach to Sleep Apnea Medicines
April 25, 2006

Protez Caps Series B Round at $21 Million - -Files Phase 1 Clinical Trail Application